Christine Zhou started her career as a physician and clocked nearly two decades at drugmaker Eli Lilly before joining rival Novo Nordisk in 2018, where she is now president for the China region. China ...

A new study shows semaglutide medications, such as Ozempic and Wegovy, may be effective in treating hidradenitis suppurativa ...

Novo Nordisk and Viatris have agreed to resolve a patent dispute over Novo's blockbuster weight-loss drugs Ozempic and Wegovy ...

In a major milestone the obesity rate dropped by roughly 2% between 2020 and 2023 according to the national health and ...

There’s a lot to think about when you're pregnant or trying to get pregnant. If you take Ozempic®, you’ll need to talk with ...

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...

NBC’s Anne Thompson sits down with Julie Spangler, a breast cancer survivor who volunteers with The Cancer Society, to provide current cancer patients with free rides to their life-saving treatments.

The world's richest man, Elon Musk, has reportedly undergone a transformation, including plastic surgery, hair transplants ...

Novo Nordisk says Massachusetts plays a key role in its bid to expand beyond its historic focus as a diabetes and obesity ...

Regeneron, a leading biotech firm, is testing a drug called trevogrumab to preserve lean muscle while using these medications ...

Mylan and Novo Nordisk have reached a confidential settlement over the generic version of Ozempic, with Natco Pharma holding ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...